Skip to main content

Table 1 EGFR inhibitors-sensitive versus resistant cell lines datasets used in metaanalysis of microarrays

From: Transcriptional changes associated with resistance to inhibitors of epidermal growth factor receptor revealed using metaanalysis

Sr. No Acc. No. Platform Set S+R S cell lines R Cell lines Cell Type Pretreatment Inhibitor
1 GSE34228 Agilent-014850 1 26+26 PC9 PC9GR Non-Small Cell Lung Cancer No Gefitinib
    2 26+26 PC9 PC9GR Non-Small Cell Lung Cancer EGF Gefitinib
    3 26+26 PC9 PC9GR Non-Small Cell Lung Cancer IRS Gefitinib
    4 26+26 PC9 PC9GR Non-Small Cell Lung Cancer EGF+IRS Gefitinib
2 GSE10696 Affy HG_ U133_Plus_2.0 1 3+3 A431 A431GR A431 cancer cell line No Gefitinib
3 GSE38310 Illumina HumanHT-12 V3.0 1 3+3 HCC827 T15-2 Non-Small Cell Lung Cancer DMSO Erlotinib
    2 3+3 HCC827 T15-3 Non-Small Cell Lung Cancer Erlotinib Erlotinib
    3 3+3 HCC827 ER-3 Non-Small Cell Lung Cancer DMSO Erlotinib
    4 3+3 HCC827 ER-3 Non-Small Cell Lung Cancer Erlotinib Erlotinib
4 GSE40130 Illumina HumanWG-6 v3.0 1 2+3 HN5 FADU Head and Neck cancer cell lines No Erlotinib
   Illumina HumanHT-12 V4.0 2 2+3 HN5 FADU Head and Neck cancer cell lines miR-7 Erlotinib
5 GSE49135 Illumina HumanHT-12 V4.0 1 3+3 HN5 HN5ER Head and Neck cancer cell lines No Erlotinib
6 GSE37699 Affy_HG_U133A_2 1 3+3 NSCLC NCl-H1975 Non-Small Cell Lung Cancer No WZ4002
7 GSE38404 Affy_HG_U133A_2 1 2+6 NSCLC PFR31, PFR32 Non-Small Cell Lung Cancer No PF299804
8 GSE21483 Affy HG_ U133_Plus_2.0 1 3+3 SCC1 1Cc8 Skin cancer cell line No Cetuximab
  Total   15 274